Transmembrane serine protease TADG-15 (ST14/Matriptase/MT-SP1): expression and prognostic value in ovarian cancer

[1]  George M Yousef,et al.  Human tissue kallikreins: a family of new cancer biomarkers. , 2002, Clinical chemistry.

[2]  Baljit Singh,et al.  Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  Robert Huber,et al.  Catalytic Domain Structures of MT-SP1/Matriptase, a Matrix-degrading Transmembrane Serine Proteinase* , 2002, The Journal of Biological Chemistry.

[4]  D. Katsaros,et al.  Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies. , 2001, Cancer research.

[5]  R. Dickson,et al.  Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. , 2001, The American journal of pathology.

[6]  J. Clements,et al.  Type II Transmembrane Serine Proteases , 2001, The Journal of Biological Chemistry.

[7]  K. Shigemasa,et al.  Ovarian Tumor Cells Express a Transmembrane Serine Protease: A Potential Candidate for Early Diagnosis and Therapeutic Intervention , 2000, Tumor Biology.

[8]  R. Dickson,et al.  Activation of Hepatocyte Growth Factor and Urokinase/Plasminogen Activator by Matriptase, an Epithelial Membrane Serine Protease* , 2000, The Journal of Biological Chemistry.

[9]  K. Shigemasa,et al.  Ovarian tumor cells express a novel multi-domain cell surface serine protease. , 2000, Biochimica et biophysica acta.

[10]  Jennifer L. Harris,et al.  Cellular Localization of Membrane-type Serine Protease 1 and Identification of Protease-activated Receptor-2 and Single-chain Urokinase-type Plasminogen Activator as Substrates* , 2000, The Journal of Biological Chemistry.

[11]  John Clarke,et al.  The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells , 1999, Cancer.

[12]  C. Craik,et al.  Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Shigemasa,et al.  Cloning of tumor-associated differentially expressed gene-14, a novel serine protease overexpressed by ovarian carcinoma. , 1999, Cancer research.

[14]  M. Johnson,et al.  Molecular Cloning of cDNA for Matriptase, a Matrix-degrading Serine Protease with Trypsin-like Activity* , 1999, The Journal of Biological Chemistry.

[15]  R. Schwartz,et al.  Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains , 1999, Immunogenetics.

[16]  K. Shigemasa,et al.  Increased Expression of Protease M in Ovarian Tumors , 1999, Tumor Biology.

[17]  B. Schlegelberger,et al.  Assignment1 of human putative tumor suppressor genes ST13 (alias SNC6) and ST14 (alias SNC19) to human chromosome bands 22q13 and 11q24→q25 by in situ hybridization , 1999, Cytogenetic and Genome Research.

[18]  D. Wazer,et al.  The role for NES1 serine protease as a novel tumor suppressor. , 1998, Cancer research.

[19]  K. Shigemasa,et al.  Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. , 1997, Cancer Research.

[20]  K. Shigemasa,et al.  p21: a monitor of p53 dysfunction in ovarian neoplasia , 1997 .

[21]  A. Wellstein,et al.  Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells. , 1993, Cancer research.

[22]  M. Duffy.  The role of proteolytic enzymes in cancer invasion and metastasis , 1992, Clinical & Experimental Metastasis.

[23]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[24]  T. Salo,et al.  Proteolytic degradation of extracellular matrix in tumor invasion. , 1987, Biochimica et biophysica acta.

[25]  D. Rifkin,et al.  Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade , 1986, Cell.

[26]  Qingyu Wu.  Type II transmembrane serine proteases. , 2003, Current topics in developmental biology.